France · Biotechnology startup

M2I Life Sciences

M2I Vision : Build in France a world-class industrial partner for custom synthesis and formulation of niche products in Healthcare (mainly generics), veterinary art, biological cro

Funding reportedLast round: Debt Financing

BiotechnologySaint Cloud, France

About M2I Life Sciences

M2I Vision : Build in France a world-class industrial partner for custom synthesis and formulation of niche products in Healthcare (mainly generics), veterinary art, biological cro

p protection and organic electronics (Re)design synthetic routes and industrial processes for « hard to make » molecules (core capability) Propose to our clients a one stop shop from specification to regulatory clearance (DMF, MA) by teaming up with R&D and marketing teams The company operates a R&D center rance and a cGMP manufacturing plant. M2I holds a portfolio of proprietary DMFs and has already successfully applied its nonconventional retrosynthetic approach of active ingredients, using continuus processing, to solve important quality and stability issues on proprietary APIs. M2I also develops pheromones based solutions for crop protection and veterinary art. M2I works in close partnership with its clients to develop and supply high quality molecules in a cost efficient way.

What company datasets say M2I Life Sciences raised

Funding, as reported

Reported in all79.2Min the source's currency
Last roundDebt Financing
Last round dateNov 2020

Biotechnology in France

Startups like it

Is this your company?

Add your raise, your deck and your story, and put M2I Life Sciences in front of investors. Or tell us what we have wrong.